Based on the above reports, we infer that PDB could synergistically act on DM as well as NAFLD by restoring insulin secretion and reducing the risk of initiation and progression of liver-associated disorders by suppressing insulin resistance. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.